Swiss franc strength puts Roche's results in a poor light
Roche has started its financial reporting for 2026 with a 5% fall in first-quarter revenues, but says its underlying performance remains strong.
Newsletters and Deep Dive digital magazine
Roche has started its financial reporting for 2026 with a 5% fall in first-quarter revenues, but says its underlying performance remains strong.
Sanofi's new chief executive, Belén Garijo, will see her tenure at the company kick-started by a strong 2026 first quarter.
AbbVie's $100bn programme of facility investments in the US has continued with a new 185-acre campus in Durham, North Carolina.
MSD has agreed a deal with Google Cloud that will put the tech giant's AI tools in the hands of its 75,000 employees worldwide.
The FDA has extended its review of a new version of Sanofi's multiple myeloma Sarclisa that could help narrow the gap with arch-rival Darzalex.
Editor's Picks
Newsletters and Deep Dive
digital magazine